STRATA CRITICAL MEDICAL, INC. Operating Cash Flow
STRATA CRITICAL MEDICAL, INC. (SRTA) reported Operating Cash Flow of $9.57 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-04
- STRATA CRITICAL MEDICAL, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was $5.69M.
- STRATA CRITICAL MEDICAL, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was $3.88M.
- STRATA CRITICAL MEDICAL, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$8.31M.
- STRATA CRITICAL MEDICAL, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$37.30M, a 686.89% decline year-over-year.
- STRATA CRITICAL MEDICAL, INC. net cash provided by (used in) operating activities for fiscal 2025 was -$48.91M.
- STRATA CRITICAL MEDICAL, INC. net cash provided by (used in) operating activities for fiscal 2024 was -$2.52M.
- STRATA CRITICAL MEDICAL, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$32.35M.
- STRATA CRITICAL MEDICAL, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$37.13M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 4 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 7 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $5.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $9.57M 10-Q · filed 2026-08-04 | $1.26M derived: sum of 3 quarters · filed 2026-08-04 | -$36.03M derived: sum of 4 quarters · filed 2026-08-04 | |||
| 2026-03-31 | $3.88M 10-Q · filed 2026-05-06 | -$4.42M derived: sum of 2 quarters · filed 2026-05-06 | -$41.72M derived: sum of 3 quarters · filed 2026-05-06 | -$44.78M derived: sum of 4 quarters · filed 2026-08-04 | |||
| 2025-12-31 | -$8.31M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | -$45.60M derived: sum of 2 quarters · filed 2026-03-03 | -$48.67M derived: sum of 3 quarters · filed 2026-08-04 | -$48.91M 10-K · filed 2026-03-03 | |||
| 2025-09-30 | -$37.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$40.36M derived: sum of 2 quarters · filed 2026-08-04 | -$40.61M 10-Q · filed 2025-11-10 | -$42.36M derived: sum of 4 quarters · filed 2026-08-04 | |||
| 2025-06-30 | -$3.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$3.31M 10-Q · filed 2026-08-04 | -$5.06M derived: sum of 3 quarters · filed 2026-08-04 | $1.29M derived: sum of 4 quarters · filed 2026-08-04 | |||
| 2025-03-31 | -$246.00K 10-Q · filed 2026-05-06 | -$2.00M derived: sum of 2 quarters · filed 2026-05-06 | $4.36M derived: sum of 3 quarters · filed 2026-05-06 | $12.79M derived: sum of 4 quarters · filed 2026-05-06 | |||
| 2024-12-31 | -$1.75M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $4.60M derived: sum of 2 quarters · filed 2026-03-03 | $13.03M derived: sum of 3 quarters · filed 2026-03-03 | -$2.52M 10-K · filed 2026-03-03 | |||
| 2024-09-30 | $6.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $14.78M derived: sum of 2 quarters · filed 2025-11-10 | -$767.00K 10-Q · filed 2025-11-10 | -$10.09M derived: sum of 4 quarters · filed 2025-11-10 | |||
| 2024-06-30 | $8.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$7.12M 10-Q · filed 2025-08-05 | -$16.44M derived: sum of 3 quarters · filed 2025-08-05 | -$14.42M derived: sum of 4 quarters · filed 2025-08-05 | |||
| 2024-03-31 | -$15.55M 10-Q · filed 2025-05-12 | -$24.87M derived: sum of 2 quarters · filed 2025-05-12 | -$22.85M derived: sum of 3 quarters · filed 2025-05-12 | -$31.05M derived: sum of 4 quarters · filed 2025-05-12 | |||
| 2023-12-31 | -$9.32M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | -$7.30M derived: sum of 2 quarters · filed 2025-03-13 | -$15.49M derived: sum of 3 quarters · filed 2025-03-13 | -$32.35M 10-K · filed 2025-03-13 | |||
| 2023-09-30 | $2.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$6.17M derived: sum of 2 quarters · filed 2024-11-12 | -$23.03M 10-Q · filed 2024-11-12 | -$32.13M derived: sum of 4 quarters · filed 2024-11-12 | |||
| 2023-06-30 | -$8.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$25.05M 10-Q · filed 2024-08-08 | -$34.16M derived: sum of 3 quarters · filed 2024-08-08 | -$40.51M derived: sum of 4 quarters · filed 2024-08-08 | |||
| 2023-03-31 | -$16.86M 10-Q · filed 2024-05-07 | -$25.96M derived: sum of 2 quarters · filed 2024-05-07 | -$32.31M derived: sum of 3 quarters · filed 2024-05-07 | -$43.92M derived: sum of 4 quarters · filed 2024-05-07 | |||
| 2022-12-31 | -$9.10M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | -$15.46M derived: sum of 2 quarters · filed 2024-03-12 | -$27.07M derived: sum of 3 quarters · filed 2024-03-12 | -$37.13M 10-K · filed 2024-03-12 | |||
| 2022-09-30 | -$6.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$17.96M derived: sum of 2 quarters · filed 2023-11-08 | -$28.03M 10-Q · filed 2023-11-08 | -$34.04M derived: sum of 4 quarters · filed 2023-11-08 | |||
| 2022-06-30 | -$11.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$21.68M 10-Q · filed 2023-08-09 | -$27.69M derived: sum of 3 quarters · filed 2023-08-09 | -$33.48M derived: sum of 4 quarters · filed 2023-08-09 | |||
| 2022-03-31 | -$10.06M 10-Q · filed 2023-05-11 | -$16.08M derived: sum of 2 quarters · filed 2023-05-11 | -$21.87M derived: sum of 3 quarters · filed 2023-05-11 | -$31.09M derived: sum of 4 quarters · filed 2023-05-11 | |||
| 2021-12-31 | -$6.02M 10-K · filed 2023-03-16 | -$11.81M derived: sum of 2 quarters · filed 2023-03-16 | -$21.02M derived: sum of 3 quarters · filed 2023-03-16 | -$21.63M derived: sum of 4 quarters · filed 2023-03-16 | |||
| 2021-09-30 | -$5.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$15.01M derived: sum of 2 quarters · filed 2022-11-10 | -$15.61M 10-Q · filed 2022-11-10 | -$15.62M 10-K · filed 2023-03-16 | |||
| 2021-06-30 | -$9.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$9.82M 10-Q · filed 2022-08-09 | -$9.82M 10-Q · filed 2021-08-16 | -$9.95M derived: sum of 4 quarters · filed 2023-01-10 | |||
| 2021-03-31 | -$605.00K 10-Q · filed 2022-05-10 | -$360.85K 10-Q · filed 2021-05-24 | -$607.00K derived: sum of 2 quarters · filed 2023-01-10 | -$734.93K derived: sum of 3 quarters · filed 2023-01-10 | -$810.79K derived: sum of 4 quarters · filed 2023-01-10 | ||
| 2020-12-31 | -$2.00K 8-K · filed 2023-01-10 | -$129.93K derived: sum of 2 quarters · filed 2023-01-10 | -$205.79K derived: sum of 3 quarters · filed 2023-01-10 | -$794.47K 10-K/A · filed 2021-05-07 | |||
| 2020-09-30 | -$127.93K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | -$203.79K derived: sum of 2 quarters · filed 2020-11-10 | -$416.06K 10-Q · filed 2020-11-10 | -$10.82M 10-K · filed 2021-12-20 | |||
| 2020-06-30 | -$75.86K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | -$288.13K 10-Q · filed 2020-08-13 | -$9.91M 10-Q · filed 2021-08-16 | ||||
| 2020-03-31 | -$212.27K 10-Q · filed 2021-05-24 | ||||||
| 2019-12-31 | -$256.51K 10-K/A · filed 2021-05-07 | ||||||
| 2019-09-30 | -$1.30K 10-Q · filed 2020-11-10 | -$10.30M 10-K · filed 2021-12-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |